The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Rebamipide is a white crystalline powder; it is odorless and has a bitter taste. It is soluble in dimethylformamide, very slightly soluble in ethanol or methanol, and insoluble in water. It has the function of scavenge hydroxyl free radicals, protects gastric mucosa damage caused by free radicals by reducing lipid peroxidation, and can inhibit inflammatory cell infiltration and Helicobacter pylori.
The global Rebamipide market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Rebamipide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Rebamipide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Rebamipide include Anlon Healthcare Pvt Ltd, Suzhou Tianma Pharmaceutical Group, Menovo, Macleods Pharma, Saurav Chemicals, SAMOH Pharm, Kyung Dong Pharm, Strides Pharma Science and Dong Wha Pharm, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Rebamipide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rebamipide.
Report Scope
The Rebamipide market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rebamipide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rebamipide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Anlon Healthcare Pvt Ltd
Suzhou Tianma Pharmaceutical Group
Menovo
Macleods Pharma
Saurav Chemicals
SAMOH Pharm
Kyung Dong Pharm
Strides Pharma Science
Dong Wha Pharm
Cheer Fine Pharmaceutical
Otsuka Pharmaceutical
Yuanlijian Pharmaceutical
Pfizer
Segment by Type
Pharmacy
Capsule
Segment by Application
Pharmacy
Hospital
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Rebamipide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Rebamipide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Rebamipide is a white crystalline powder; it is odorless and has a bitter taste. It is soluble in dimethylformamide, very slightly soluble in ethanol or methanol, and insoluble in water. It has the function of scavenge hydroxyl free radicals, protects gastric mucosa damage caused by free radicals by reducing lipid peroxidation, and can inhibit inflammatory cell infiltration and Helicobacter pylori.
The global Rebamipide market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Rebamipide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Rebamipide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Rebamipide include Anlon Healthcare Pvt Ltd, Suzhou Tianma Pharmaceutical Group, Menovo, Macleods Pharma, Saurav Chemicals, SAMOH Pharm, Kyung Dong Pharm, Strides Pharma Science and Dong Wha Pharm, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Rebamipide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rebamipide.
Report Scope
The Rebamipide market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rebamipide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rebamipide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Anlon Healthcare Pvt Ltd
Suzhou Tianma Pharmaceutical Group
Menovo
Macleods Pharma
Saurav Chemicals
SAMOH Pharm
Kyung Dong Pharm
Strides Pharma Science
Dong Wha Pharm
Cheer Fine Pharmaceutical
Otsuka Pharmaceutical
Yuanlijian Pharmaceutical
Pfizer
Segment by Type
Pharmacy
Capsule
Segment by Application
Pharmacy
Hospital
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Rebamipide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Rebamipide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Rebamipide Market Overview
1.1 Product Overview and Scope of Rebamipide
1.2 Rebamipide Segment by Type
1.2.1 Global Rebamipide Market Value Comparison by Type (2024-2030)
1.2.2 Pharmacy
1.2.3 Capsule
1.3 Rebamipide Segment by Application
1.3.1 Global Rebamipide Market Value by Application: (2024-2030)
1.3.2 Pharmacy
1.3.3 Hospital
1.3.4 Others
1.4 Global Rebamipide Market Size Estimates and Forecasts
1.4.1 Global Rebamipide Revenue 2019-2030
1.4.2 Global Rebamipide Sales 2019-2030
1.4.3 Global Rebamipide Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Rebamipide Market Competition by Manufacturers
2.1 Global Rebamipide Sales Market Share by Manufacturers (2019-2024)
2.2 Global Rebamipide Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Rebamipide Average Price by Manufacturers (2019-2024)
2.4 Global Rebamipide Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Rebamipide, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Rebamipide, Product Type & Application
2.7 Rebamipide Market Competitive Situation and Trends
2.7.1 Rebamipide Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Rebamipide Players Market Share by Revenue
2.7.3 Global Rebamipide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Rebamipide Retrospective Market Scenario by Region
3.1 Global Rebamipide Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Rebamipide Global Rebamipide Sales by Region: 2019-2030
3.2.1 Global Rebamipide Sales by Region: 2019-2024
3.2.2 Global Rebamipide Sales by Region: 2025-2030
3.3 Global Rebamipide Global Rebamipide Revenue by Region: 2019-2030
3.3.1 Global Rebamipide Revenue by Region: 2019-2024
3.3.2 Global Rebamipide Revenue by Region: 2025-2030
3.4 North America Rebamipide Market Facts & Figures by Country
3.4.1 North America Rebamipide Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Rebamipide Sales by Country (2019-2030)
3.4.3 North America Rebamipide Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Rebamipide Market Facts & Figures by Country
3.5.1 Europe Rebamipide Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Rebamipide Sales by Country (2019-2030)
3.5.3 Europe Rebamipide Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Rebamipide Market Facts & Figures by Country
3.6.1 Asia Pacific Rebamipide Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Rebamipide Sales by Country (2019-2030)
3.6.3 Asia Pacific Rebamipide Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Rebamipide Market Facts & Figures by Country
3.7.1 Latin America Rebamipide Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Rebamipide Sales by Country (2019-2030)
3.7.3 Latin America Rebamipide Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Rebamipide Market Facts & Figures by Country
3.8.1 Middle East and Africa Rebamipide Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Rebamipide Sales by Country (2019-2030)
3.8.3 Middle East and Africa Rebamipide Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Rebamipide Sales by Type (2019-2030)
4.1.1 Global Rebamipide Sales by Type (2019-2024)
4.1.2 Global Rebamipide Sales by Type (2025-2030)
4.1.3 Global Rebamipide Sales Market Share by Type (2019-2030)
4.2 Global Rebamipide Revenue by Type (2019-2030)
4.2.1 Global Rebamipide Revenue by Type (2019-2024)
4.2.2 Global Rebamipide Revenue by Type (2025-2030)
4.2.3 Global Rebamipide Revenue Market Share by Type (2019-2030)
4.3 Global Rebamipide Price by Type (2019-2030)
5 Segment by Application
5.1 Global Rebamipide Sales by Application (2019-2030)
5.1.1 Global Rebamipide Sales by Application (2019-2024)
5.1.2 Global Rebamipide Sales by Application (2025-2030)
5.1.3 Global Rebamipide Sales Market Share by Application (2019-2030)
5.2 Global Rebamipide Revenue by Application (2019-2030)
5.2.1 Global Rebamipide Revenue by Application (2019-2024)
5.2.2 Global Rebamipide Revenue by Application (2025-2030)
5.2.3 Global Rebamipide Revenue Market Share by Application (2019-2030)
5.3 Global Rebamipide Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Anlon Healthcare Pvt Ltd
6.1.1 Anlon Healthcare Pvt Ltd Corporation Information
6.1.2 Anlon Healthcare Pvt Ltd Description and Business Overview
6.1.3 Anlon Healthcare Pvt Ltd Rebamipide Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Anlon Healthcare Pvt Ltd Rebamipide Product Portfolio
6.1.5 Anlon Healthcare Pvt Ltd Recent Developments/Updates
6.2 Suzhou Tianma Pharmaceutical Group
6.2.1 Suzhou Tianma Pharmaceutical Group Corporation Information
6.2.2 Suzhou Tianma Pharmaceutical Group Description and Business Overview
6.2.3 Suzhou Tianma Pharmaceutical Group Rebamipide Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Suzhou Tianma Pharmaceutical Group Rebamipide Product Portfolio
6.2.5 Suzhou Tianma Pharmaceutical Group Recent Developments/Updates
6.3 Menovo
6.3.1 Menovo Corporation Information
6.3.2 Menovo Description and Business Overview
6.3.3 Menovo Rebamipide Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Menovo Rebamipide Product Portfolio
6.3.5 Menovo Recent Developments/Updates
6.4 Macleods Pharma
6.4.1 Macleods Pharma Corporation Information
6.4.2 Macleods Pharma Description and Business Overview
6.4.3 Macleods Pharma Rebamipide Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Macleods Pharma Rebamipide Product Portfolio
6.4.5 Macleods Pharma Recent Developments/Updates
6.5 Saurav Chemicals
6.5.1 Saurav Chemicals Corporation Information
6.5.2 Saurav Chemicals Description and Business Overview
6.5.3 Saurav Chemicals Rebamipide Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Saurav Chemicals Rebamipide Product Portfolio
6.5.5 Saurav Chemicals Recent Developments/Updates
6.6 SAMOH Pharm
6.6.1 SAMOH Pharm Corporation Information
6.6.2 SAMOH Pharm Description and Business Overview
6.6.3 SAMOH Pharm Rebamipide Sales, Revenue and Gross Margin (2019-2024)
6.6.4 SAMOH Pharm Rebamipide Product Portfolio
6.6.5 SAMOH Pharm Recent Developments/Updates
6.7 Kyung Dong Pharm
6.6.1 Kyung Dong Pharm Corporation Information
6.6.2 Kyung Dong Pharm Description and Business Overview
6.6.3 Kyung Dong Pharm Rebamipide Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Kyung Dong Pharm Rebamipide Product Portfolio
6.7.5 Kyung Dong Pharm Recent Developments/Updates
6.8 Strides Pharma Science
6.8.1 Strides Pharma Science Corporation Information
6.8.2 Strides Pharma Science Description and Business Overview
6.8.3 Strides Pharma Science Rebamipide Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Strides Pharma Science Rebamipide Product Portfolio
6.8.5 Strides Pharma Science Recent Developments/Updates
6.9 Dong Wha Pharm
6.9.1 Dong Wha Pharm Corporation Information
6.9.2 Dong Wha Pharm Description and Business Overview
6.9.3 Dong Wha Pharm Rebamipide Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Dong Wha Pharm Rebamipide Product Portfolio
6.9.5 Dong Wha Pharm Recent Developments/Updates
6.10 Cheer Fine Pharmaceutical
6.10.1 Cheer Fine Pharmaceutical Corporation Information
6.10.2 Cheer Fine Pharmaceutical Description and Business Overview
6.10.3 Cheer Fine Pharmaceutical Rebamipide Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Cheer Fine Pharmaceutical Rebamipide Product Portfolio
6.10.5 Cheer Fine Pharmaceutical Recent Developments/Updates
6.11 Otsuka Pharmaceutical
6.11.1 Otsuka Pharmaceutical Corporation Information
6.11.2 Otsuka Pharmaceutical Rebamipide Description and Business Overview
6.11.3 Otsuka Pharmaceutical Rebamipide Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Otsuka Pharmaceutical Rebamipide Product Portfolio
6.11.5 Otsuka Pharmaceutical Recent Developments/Updates
6.12 Yuanlijian Pharmaceutical
6.12.1 Yuanlijian Pharmaceutical Corporation Information
6.12.2 Yuanlijian Pharmaceutical Rebamipide Description and Business Overview
6.12.3 Yuanlijian Pharmaceutical Rebamipide Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Yuanlijian Pharmaceutical Rebamipide Product Portfolio
6.12.5 Yuanlijian Pharmaceutical Recent Developments/Updates
6.13 Pfizer
6.13.1 Pfizer Corporation Information
6.13.2 Pfizer Rebamipide Description and Business Overview
6.13.3 Pfizer Rebamipide Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Pfizer Rebamipide Product Portfolio
6.13.5 Pfizer Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Rebamipide Industry Chain Analysis
7.2 Rebamipide Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Rebamipide Production Mode & Process
7.4 Rebamipide Sales and Marketing
7.4.1 Rebamipide Sales Channels
7.4.2 Rebamipide Distributors
7.5 Rebamipide Customers
8 Rebamipide Market Dynamics
8.1 Rebamipide Industry Trends
8.2 Rebamipide Market Drivers
8.3 Rebamipide Market Challenges
8.4 Rebamipide Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Rebamipide Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Rebamipide Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Rebamipide Market Competitive Situation by Manufacturers in 2023
Table 4. Global Rebamipide Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Rebamipide Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Rebamipide Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Rebamipide Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Rebamipide Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Rebamipide, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Rebamipide, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Rebamipide, Product Type & Application
Table 12. Global Key Manufacturers of Rebamipide, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Rebamipide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rebamipide as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Rebamipide Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Rebamipide Sales by Region (2019-2024) & (K Units)
Table 18. Global Rebamipide Sales Market Share by Region (2019-2024)
Table 19. Global Rebamipide Sales by Region (2025-2030) & (K Units)
Table 20. Global Rebamipide Sales Market Share by Region (2025-2030)
Table 21. Global Rebamipide Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Rebamipide Revenue Market Share by Region (2019-2024)
Table 23. Global Rebamipide Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Rebamipide Revenue Market Share by Region (2025-2030)
Table 25. North America Rebamipide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Rebamipide Sales by Country (2019-2024) & (K Units)
Table 27. North America Rebamipide Sales by Country (2025-2030) & (K Units)
Table 28. North America Rebamipide Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Rebamipide Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Rebamipide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Rebamipide Sales by Country (2019-2024) & (K Units)
Table 32. Europe Rebamipide Sales by Country (2025-2030) & (K Units)
Table 33. Europe Rebamipide Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Rebamipide Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Rebamipide Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Rebamipide Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Rebamipide Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Rebamipide Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Rebamipide Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Rebamipide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Rebamipide Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Rebamipide Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Rebamipide Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Rebamipide Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Rebamipide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Rebamipide Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Rebamipide Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Rebamipide Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Rebamipide Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Rebamipide Sales (K Units) by Type (2019-2024)
Table 51. Global Rebamipide Sales (K Units) by Type (2025-2030)
Table 52. Global Rebamipide Sales Market Share by Type (2019-2024)
Table 53. Global Rebamipide Sales Market Share by Type (2025-2030)
Table 54. Global Rebamipide Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Rebamipide Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Rebamipide Revenue Market Share by Type (2019-2024)
Table 57. Global Rebamipide Revenue Market Share by Type (2025-2030)
Table 58. Global Rebamipide Price (US$/Unit) by Type (2019-2024)
Table 59. Global Rebamipide Price (US$/Unit) by Type (2025-2030)
Table 60. Global Rebamipide Sales (K Units) by Application (2019-2024)
Table 61. Global Rebamipide Sales (K Units) by Application (2025-2030)
Table 62. Global Rebamipide Sales Market Share by Application (2019-2024)
Table 63. Global Rebamipide Sales Market Share by Application (2025-2030)
Table 64. Global Rebamipide Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Rebamipide Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Rebamipide Revenue Market Share by Application (2019-2024)
Table 67. Global Rebamipide Revenue Market Share by Application (2025-2030)
Table 68. Global Rebamipide Price (US$/Unit) by Application (2019-2024)
Table 69. Global Rebamipide Price (US$/Unit) by Application (2025-2030)
Table 70. Anlon Healthcare Pvt Ltd Corporation Information
Table 71. Anlon Healthcare Pvt Ltd Description and Business Overview
Table 72. Anlon Healthcare Pvt Ltd Rebamipide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Anlon Healthcare Pvt Ltd Rebamipide Product
Table 74. Anlon Healthcare Pvt Ltd Recent Developments/Updates
Table 75. Suzhou Tianma Pharmaceutical Group Corporation Information
Table 76. Suzhou Tianma Pharmaceutical Group Description and Business Overview
Table 77. Suzhou Tianma Pharmaceutical Group Rebamipide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Suzhou Tianma Pharmaceutical Group Rebamipide Product
Table 79. Suzhou Tianma Pharmaceutical Group Recent Developments/Updates
Table 80. Menovo Corporation Information
Table 81. Menovo Description and Business Overview
Table 82. Menovo Rebamipide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Menovo Rebamipide Product
Table 84. Menovo Recent Developments/Updates
Table 85. Macleods Pharma Corporation Information
Table 86. Macleods Pharma Description and Business Overview
Table 87. Macleods Pharma Rebamipide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Macleods Pharma Rebamipide Product
Table 89. Macleods Pharma Recent Developments/Updates
Table 90. Saurav Chemicals Corporation Information
Table 91. Saurav Chemicals Description and Business Overview
Table 92. Saurav Chemicals Rebamipide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Saurav Chemicals Rebamipide Product
Table 94. Saurav Chemicals Recent Developments/Updates
Table 95. SAMOH Pharm Corporation Information
Table 96. SAMOH Pharm Description and Business Overview
Table 97. SAMOH Pharm Rebamipide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. SAMOH Pharm Rebamipide Product
Table 99. SAMOH Pharm Recent Developments/Updates
Table 100. Kyung Dong Pharm Corporation Information
Table 101. Kyung Dong Pharm Description and Business Overview
Table 102. Kyung Dong Pharm Rebamipide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Kyung Dong Pharm Rebamipide Product
Table 104. Kyung Dong Pharm Recent Developments/Updates
Table 105. Strides Pharma Science Corporation Information
Table 106. Strides Pharma Science Description and Business Overview
Table 107. Strides Pharma Science Rebamipide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Strides Pharma Science Rebamipide Product
Table 109. Strides Pharma Science Recent Developments/Updates
Table 110. Dong Wha Pharm Corporation Information
Table 111. Dong Wha Pharm Description and Business Overview
Table 112. Dong Wha Pharm Rebamipide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Dong Wha Pharm Rebamipide Product
Table 114. Dong Wha Pharm Recent Developments/Updates
Table 115. Cheer Fine Pharmaceutical Corporation Information
Table 116. Cheer Fine Pharmaceutical Description and Business Overview
Table 117. Cheer Fine Pharmaceutical Rebamipide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Cheer Fine Pharmaceutical Rebamipide Product
Table 119. Cheer Fine Pharmaceutical Recent Developments/Updates
Table 120. Otsuka Pharmaceutical Corporation Information
Table 121. Otsuka Pharmaceutical Description and Business Overview
Table 122. Otsuka Pharmaceutical Rebamipide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Otsuka Pharmaceutical Rebamipide Product
Table 124. Otsuka Pharmaceutical Recent Developments/Updates
Table 125. Yuanlijian Pharmaceutical Corporation Information
Table 126. Yuanlijian Pharmaceutical Description and Business Overview
Table 127. Yuanlijian Pharmaceutical Rebamipide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Yuanlijian Pharmaceutical Rebamipide Product
Table 129. Yuanlijian Pharmaceutical Recent Developments/Updates
Table 130. Pfizer Corporation Information
Table 131. Pfizer Description and Business Overview
Table 132. Pfizer Rebamipide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Pfizer Rebamipide Product
Table 134. Pfizer Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Rebamipide Distributors List
Table 138. Rebamipide Customers List
Table 139. Rebamipide Market Trends
Table 140. Rebamipide Market Drivers
Table 141. Rebamipide Market Challenges
Table 142. Rebamipide Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Rebamipide
Figure 2. Global Rebamipide Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Rebamipide Market Share by Type in 2023 & 2030
Figure 4. Pharmacy Product Picture
Figure 5. Capsule Product Picture
Figure 6. Global Rebamipide Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Rebamipide Market Share by Application in 2023 & 2030
Figure 8. Pharmacy
Figure 9. Hospital
Figure 10. Others
Figure 11. Global Rebamipide Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Rebamipide Market Size (2019-2030) & (US$ Million)
Figure 13. Global Rebamipide Sales (2019-2030) & (K Units)
Figure 14. Global Rebamipide Average Price (US$/Unit) & (2019-2030)
Figure 15. Rebamipide Report Years Considered
Figure 16. Rebamipide Sales Share by Manufacturers in 2023
Figure 17. Global Rebamipide Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Rebamipide Players: Market Share by Revenue in 2023
Figure 19. Rebamipide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Rebamipide Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Rebamipide Sales Market Share by Country (2019-2030)
Figure 22. North America Rebamipide Revenue Market Share by Country (2019-2030)
Figure 23. United States Rebamipide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Rebamipide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Rebamipide Sales Market Share by Country (2019-2030)
Figure 26. Europe Rebamipide Revenue Market Share by Country (2019-2030)
Figure 27. Germany Rebamipide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Rebamipide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Rebamipide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Rebamipide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Rebamipide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Rebamipide Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Rebamipide Revenue Market Share by Region (2019-2030)
Figure 34. China Rebamipide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Rebamipide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Rebamipide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Rebamipide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Rebamipide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Rebamipide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Rebamipide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Rebamipide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Rebamipide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Rebamipide Sales Market Share by Country (2019-2030)
Figure 44. Latin America Rebamipide Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Rebamipide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Rebamipide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Rebamipide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Rebamipide Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Rebamipide Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Rebamipide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Rebamipide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Rebamipide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Rebamipide by Type (2019-2030)
Figure 54. Global Revenue Market Share of Rebamipide by Type (2019-2030)
Figure 55. Global Rebamipide Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Rebamipide by Application (2019-2030)
Figure 57. Global Revenue Market Share of Rebamipide by Application (2019-2030)
Figure 58. Global Rebamipide Price (US$/Unit) by Application (2019-2030)
Figure 59. Rebamipide Value Chain
Figure 60. Rebamipide Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
